Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Boston Scientific Corp shares valued at $310,378 were sold by FUJIMORI YOSHIAKI on Jul 29 ’25. At $106.99 per share, FUJIMORI YOSHIAKI sold 2,901 shares. The insider’s holdings dropped to 2,081 shares worth approximately $0.22 million following the completion of this transaction.
Also, YOSHIAKI FUJIMORI purchased 2,901 shares, netting a total of over 310,378 in proceeds.
Before that, LUDWIG EDWARD J had sold 4,000 shares from its account. In a trade valued at $424,120, the Director traded Boston Scientific Corp shares for $106.03 each. Upon closing the transaction, the insider’s holdings decreased to 4,000 shares, worth approximately $1.97 million.
As published in their initiating research note from Leerink Partners on June 16, 2025, Boston Scientific Corp [BSX] has been an Outperform and the price target has been revised to $118. Analysts at Needham upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in mid April. As of January 10, 2025, Deutsche Bank has increased its “Hold” rating to a “Buy” for BSX. Earlier on October 18, 2024, Needham downgraded its rating. Their new recommendation was “a Hold” for BSX stock which previously was a “a Buy”.
Analyzing BSX Stock Performance
On last trading session,, Boston Scientific Corp [NYSE: BSX] rose 0.27% to $106.76. The stock’s lowest price that day was $105.88, but it reached a high of $107.23 in the same session. During the last five days, there has been a drop of approximately -0.93%. Over the course of the year, Boston Scientific Corp shares have jumped approximately 42.50%.
Support And Resistance Levels for Boston Scientific Corp (BSX)
RSI (Relative Strength Index) is 58.97 on the 14-day chart, showing neutral technical sentiment.
Is Boston Scientific Corp subject to short interest?
Stocks of Boston Scientific Corp saw a sharp rise in short interest on 2025-07-15 jumping by 2.08 million shares to 19.57 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 17.49 million shares. A jump of 10.61% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.65 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.65.
Which companies own the most shares of Boston Scientific Corp (BSX)?
In terms of Boston Scientific Corp share price expectations, FactSet research, analysts set an average price target of 119.5 in the next 12 months, up nearly 12.24% from the previous closing price of $106.47. Analysts anticipate Boston Scientific Corp stock to reach 130 by 2025, with the lowest price target being 115. In spite of this, 15 analysts ranked Boston Scientific Corp stock as Buy at the end of 2025. On May 30, 2024, Goldman assigned a price target of “a Buy” to the stock and initiated coverage with a $90.
